In cancer treatment, non-invasive diagnosis can avoid complications of biopsy
and other unfavorable impacts on patient's health. DNA, methylation, SNPs,
miRNA, mRNA, protein, autoantibodies, metabolite, and Omics based markers from
remote media (blood, serum, plasma, urine, stool, sputum, saliva, etc.) are
emerging as noninvasive molecular markers having high specificity and
sensitivity towards many cancers. In many instances these markers are also
emerging as next-generation personalized diagnostics and targets or therapeutics
for personalized cancer treatment. This book classifies the available molecular
tumor markers according to their principal characteristics and relative
methodologies.